Raily Aesthetic Medicine International (HKG:2135) expects a loss attributable to owners of about 8 million yuan for the six months ended June 30, compared with a loss of about 2 million yuan a year earlier, according to an Aug. 8 Hong Kong bourse filing.
Revenue for the period is forecast at about 85 million yuan, down from about 117 million yuan in the same period last year.
Interim results are expected by the end of August.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.